President's Welcome

Dear Colleagues, Patients, and Friends,

In recent months, the novel coronavirus pandemic (SARS-CoV-2, the virus which causes the COVID-19 disease) has demonstrated the critical importance of molecular testing for patient care and public health to a global audience. Our community has ramped up testing for COVID-19 and continued to conduct routine testing for a broad range of inherited conditions, infectious diseases and cancers - all while facing strenuous supply and staffing shortages. I am in awe of our members’ sharing of resources and expertise throughout the pandemic, and I’m truly honored to serve as president at this critical moment.

AMP members help patients every day by developing and performing advanced molecular testing to provide accurate and timely diagnosis. Our work is primarily completed in laboratory facilities, sometimes far from the doctor’s offices or hospital rooms where patients receive care. Nevertheless, we serve as an essential partner in precision medicine efforts that are improving outcomes for patients. To help patients understand the role molecular professionals play, AMP recently launched “Molecular Medicine for Patients,” with educational resources that are created with input from the patient community. I am excited for these materials to be shared with our patients and for AMP to continue to build meaningful connections with patient advocacy organizations.

AMP is recognized for its unmatched expertise in all aspects of molecular diagnostics. For over 25 years, we’ve advanced the field through education, clinical practice, and advocacy. For laboratory professionals who are new to our community or hoping to return to the field, I encourage you to take advantage of our broad range of educational offerings, including webinars and in-depth courses, and to read our freely available practice guidelines in our highly regarded academic publication, The Journal of Molecular Diagnostics (JMD). If you are or choose to become a member, we also offer discounted page charges and open access fees for corresponding authors of accepted articles when publishing in JMD.  

Finally, I can think of no better opportunity for you to learn about advancing molecular-based patient care than by attending one of our meetings. While the 2020 AMP Annual Meeting & Expo shifted to an online format due to the pandemic, I hope to see you at in-person events again soon. We will keep you informed on plans for our 2021 meetings and courses, and we thank you for your patience as we navigate these uncertain times together.

Our community’s expertise and capabilities are needed now more than ever. If you’re a molecular professional but not yet a member, I encourage you to join us and experience all that AMP has to offer!


Antonia R. Sepulveda, MD, PhD
Professor and Chair
George Washington University Department of Pathology
Association of Molecular Pathology 2021 President

Corporate Partners